Firmagon Evropska unija - slovenščina - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degareliks - prostatične neoplazme - endokrini terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Vaniqa Evropska unija - slovenščina - EMA (European Medicines Agency)

vaniqa

almirall, s.a. - eflornithine - hirsutizem - drugi dermatološki preparati - zdravljenje obraznega hirsutizma pri ženskah.

Xtandi Evropska unija - slovenščina - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamid - prostatične neoplazme - endokrini terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

ANDROTOP 20,25 mg/pritisk gel Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

androtop 20,25 mg/pritisk gel

besins healthcare sa - testosteron - gel - testosteron 20,25 mg / 1 vsebnik - testosteron

Enplerasa 25 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

enplerasa 25 mg filmsko obložene tablete

krka, d.d., novo mesto - eplerenon - filmsko obložena tableta - eplerenon 25 mg / 1 tableta - eplerenon

Enplerasa 50 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

enplerasa 50 mg filmsko obložene tablete

krka, d.d., novo mesto - eplerenon - filmsko obložena tableta - eplerenon 50 mg / 1 tableta - eplerenon

Abiraterone Accord Evropska unija - slovenščina - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Icatibant Accord Evropska unija - slovenščina - EMA (European Medicines Agency)

icatibant accord

accord healthcare s.l.u. - icatibant acetate - angioedem, dedno - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.

Abiraterone Mylan Evropska unija - slovenščina - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - abirateron acetat - prostatične neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Nephrotrans 500 mg mehke gastrorezistentne kapsule Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

nephrotrans 500 mg mehke gastrorezistentne kapsule

natrijev hidrogenkarbonat - gastrorezistentna kapsula, mehka - natrijev hidrogenkarbonat 500 mg / 1 kapsula - antacidi z natrijevim hidrogenkarbonatom